Dreman Value Management’s Charles River Laboratories CRL Stock Holding History

Dreman Value Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-57,090	Closed	-$4.33M	–	474
2016 Q1	$4.33M	Buy	+57,090	New	+$4.23M	0.49%	74
2015 Q4	–	Sell	-61,274	Closed	-$3.89M	–	236
2015 Q3	$3.89M	Buy	61,274 +2,898	+5%	+$208K	0.39%	91
2015 Q2	$4.11M	Buy	58,376 +2,054	+4%	+$152K	0.34%	108
2015 Q1	$4.47M	Sell	56,322 -60,049	-52%	-$4.43M	0.39%	98
2014 Q4	$7.41M	Buy	116,371 +5,124	+5%	+$321K	0.61%	54
2014 Q3	$6.65M	Buy	111,247 +1,377	+1%	+$78.8K	0.54%	68
2014 Q2	$5.88M	Sell	109,870 -42,289	-28%	-$2.32M	0.44%	113
2014 Q1	$9.18M	Sell	152,159 -59,913	-28%	-$3.49M	0.71%	34
2013 Q4	$11.3M	Buy	212,072 +24,195	+13%	+$1.22M	0.85%	8
2013 Q3	$8.69M	Buy	+187,877	New	+$8.62M	0.78%	14

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dreman Value Management's CRL Position: Q2 2016 in Review

Dreman Value Management sold out of Charles River Laboratories (CRL) in Q2 2016, closing a stake of 57,090 shares — an estimated $4.33M sold.

Dreman Value Management first reported a position in CRL in Q3 2013 and held it in 10 quarters. The position peaked at $11.3M in Q4 2013. 286 funds tracked by Wall St. Rank hold CRL as of Q2 2016.

Dreman Value Management reported no remaining Charles River Laboratories position as of Q2 2016 after selling out during the quarter.
Dreman Value Management sold 57,090 Charles River Laboratories shares in Q2 2016, an estimated $4.33M.
Dreman Value Management first reported a position in Charles River Laboratories in Q3 2013 and held it in 10 quarters.
Dreman Value Management's Charles River Laboratories position peaked at $11.3M in Q4 2013.
286 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2016.

Based on Dreman Value Management's 13F filing for Q2 2016, filed 15 Aug 2016.